Severe infections caused by multidrug-resistant non-fermentative bacilli in southern Poland.

BACKGROUND The impact of multidrug-resistant organisms (MDROs), including non-fermentative bacilli (NFBs), is rising and underestimated, especially in intensive care units (ICUs). The growing prevalence of multidrug resistance (MDR) and extensive drug resistance (XDR) is challenging for clinicians, as the treatment options are limited. OBJECTIVES The purpose of this study was to analyze the extent of the epidemiological problem of multidrugresistant, extensively drug-resistant and pandrug-resistant (PDR) non-fermentative bacilli isolated from pneumonia and bloodstream infections (BSIs) in patients hospitalized in southern Poland. MATERIAL AND METHODS This study included 253 NFBs belonging to Acinetobacter sp. (ACI), Pseudomonas sp. (PAR), and Stenotrophomonas sp. (STM). The microorganisms were identified, and susceptibility testing was performed using a semi-automatic system. The different patterns of resistance were defined as MDR, XDR, or PDR strains. Epidemiological typing of A. baumannii from ICUs was performed by repetitive polymerase chain reaction (rep-PCR). RESULTS More than half of the strains (57.7%) were isolated within ICUs. ACI-strains came significantly more often from ICU wards. The highest prevalence of ACI and PAR was found in pneumonia, whereas STM dominated in BSIs. ACIs were more frequently resistant than other pathogens to all studied antibiotics except colistin (n = 76; 58.9%), and they belonged to the XDR category. DiversiLab demonstrated the presence of 2 dominant clones in the ACI group, both classified as European Clone 2 (EUII). CONCLUSIONS Our results indicate serious potential therapeutic problems related to high antibiotic resistance of ACI isolates. The stratification of drug resistance (MDR/XDR/PDR) may become an important tool for the assessment of public health epidemiology and microbiological hazards at the local, national, and international level. It allows clear presentation of the issues concerning the epidemiology of highly resistant bacilli, and the exchange of information between medical staff and local representatives of public health for the implementation of effective measures to reduce drug resistance.

• Publication year

  2018

• Venue

  Advances in Clinical and Experimental Medicine

• Publication date

  2018-03-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.17219/acem/68545PMID 29533544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.

  2016cited by this paper
• Virulence and Antibiotic Resistance of Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infections in Southern Poland

  2015cited by this paper
• Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.

  2015cited by this paper
• Identification of plasmid OXA and other β-lactamase genes among carbapenem-resistant isolates of Pseudomonas aeruginosa from the Clinical University Hospital in northeastern Poland.

  2015cited by this paper
• European Centre for Disease Prevention and Control.

  2014cited by this paper
• Risks for multidrug-resistant pathogens in the ICU

  2014cited by this paper
• Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).

  2014cited by this paper
• Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study

  2014cited by this paper
• Acinetobacter baumannii: evolution of a global pathogen.

  2014cited by this paper
• New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen

  2014cited by this paper
• Activities of Vancomycin-Containing Regimens against Colistin-Resistant Acinetobacter baumannii Clinical Strains

  2013cited by this paper
• Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates

  2013cited by this paper
• Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

  2012cited by this paper
• [Clinical strains isolation and antibiotic susceptibility of Stenotrophomonas maltophilia].

  2010cited by this paper
• Global spread of carbapenem-resistant Acinetobacter baumannii.

  2010cited by this paper
• Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.

  2008cited by this paper
• Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06.

  2008cited by this paper
• Global Challenge of Multidrug-Resistant Acinetobacter baumannii

  2007cited by this paper
• Is the prevalence of Stenotrophomonas maltophilia isolation and nosocomial infection increasing in intensive care units?

  2006cited by this paper
• Acquired metallo-beta-lactamases: an increasing clinical threat.

  2005cited by this paper
• Nosocomial Infections Due to Multidrug‐Resistant Pseudomonas aeruginosa: Epidemiology and Treatment Options

  2005cited by this paper
• Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.

  2005cited by this paper
• National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002

  2004cited by this paper

• The nasal microbiota is a potential diagnostic biomarker for sepsis in critical care units

  2024cites this paper
• Carbapenem is not always the best choice in the treatment of septic shock

  2023cites this paper
• Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen Stenotrophomonas maltophilia

  2022cites this paper
• Prevalence of multidrug resistant non-fermenters in a tertiary care centre

  2022cites this paper
• Investigation of Acinetobacter baumannii Activity in Vascular Surgery Units through Epidemiological Management Based on the Analysis of Antimicrobial Resistance, Biofilm Formation and Genotyping

  2021cites this paper
• Diversity and Distribution of Resistance Markers in Pseudomonas aeruginosa International High-Risk Clones

  2021cites this paper
• Multidrug-Resistant Microorganisms Associated with Urinary Tract Infections Following Orthopaedic Patients: A Laboratory-Based Analysis of 5239 Patients

  2020cites this paper
• Cathelicidin-DM is an Antimicrobial Peptide from Duttaphrynus melanostictus and Has Wound-Healing Therapeutic Potential

  2020cites this paper
• Can surgical site infections be controlled through microbiological surveillance? A three-year laboratory-based surveillance at an orthopaedic unit, retrospective observatory study

  2019cites this paper
• Clinical Presentations and Outcomes of Post-Operative Central Nervous System Infection Caused by Multi-Drug–Resistant/Extensively Drug-Resistant Acinetobacter baumannii: A Retrospective Study

  2019cites this paper